Semicarbazide-Sensitive Amine Oxidase (SSAO) and Lysyl Oxidase (LOX) Association in Rat Aortic Vascular Smooth Muscle Cells

Vascular smooth muscle cells (VSMCs) are the main stromal cells in the medial layer of the vascular wall. These cells produce the extracellular matrix (ECM) and are involved in many pathological changes in the vascular wall. Semicarbazide-sensitive amine oxidase (SSAO) and lysyl oxidase (LOX) are va...

Full description

Bibliographic Details
Main Authors: Vesna Manasieva, Shori Thakur, Lisa A. Lione, Jessal Patel, Anwar Baydoun, John Skamarauskas
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/12/11/1563
_version_ 1797469018144112640
author Vesna Manasieva
Shori Thakur
Lisa A. Lione
Jessal Patel
Anwar Baydoun
John Skamarauskas
author_facet Vesna Manasieva
Shori Thakur
Lisa A. Lione
Jessal Patel
Anwar Baydoun
John Skamarauskas
author_sort Vesna Manasieva
collection DOAJ
description Vascular smooth muscle cells (VSMCs) are the main stromal cells in the medial layer of the vascular wall. These cells produce the extracellular matrix (ECM) and are involved in many pathological changes in the vascular wall. Semicarbazide-sensitive amine oxidase (SSAO) and lysyl oxidase (LOX) are vascular enzymes associated with the development of atherosclerosis. In the vascular smooth muscle cells, increased SSAO activity elevates reactive oxygen species (ROS) and induces VSMCs death; increased LOX induces chemotaxis through hydrogen peroxide dependent mechanisms; and decreased LOX contributes to endothelial dysfunction. This study investigates the relationship between SSAO and LOX in VSMCs by studying their activity, protein, and mRNA levels during VSMCs passaging and after silencing the LOX gene, while using their respective substrates and inhibitors. At the basal level, LOX activity decreased with passage and its protein expression was maintained between passages. βAPN abolished LOX activity (** <i>p</i> < 0.01 for 8 vs. 3 and * <i>p</i> < 0.05 for 5 vs. 8) and had no effect on LOX protein and mRNA levels. MDL72527 reduced LOX activity at passage 3 and 5 (<sup>##</sup> <i>p</i> < 0.01) and had no effect on LOX protein, and mRNA expression. At the basal level, SSAO activity also decreased with passage, and its protein expression was maintained between passages. MDL72527 abolished SSAO activity (**** <i>p</i> < 0.0001 for 8 vs. 3 and * <i>p</i> < 0.05 for 5 vs. 8), VAP-1 expression at passage 5 (** <i>p</i> < 0.01) and 8 (**** <i>p</i> < 0.0001), and Aoc3 mRNA levels at passage 8 (* <i>p</i> < 0.05). βAPN inhibited SSAO activity (**** <i>p</i> < 0.0001 for 5 vs. 3 and 8 vs. 3 and * <i>p</i> < 0.05 for 5 vs. 8), VAP-1 expression at passage 3 (* <i>p</i> < 0.05), and Aoc3 mRNA levels at passage 3 (* <i>p</i> < 0.05). Knockdown of the LOX gene (**** <i>p</i> < 0.0001 for Si6 vs. Sictrl and *** <i>p</i> < 0.001 for Si8 vs. Sictrl) and LOX protein (** <i>p</i> < 0.01 for Si6 and Si8 vs. Sictrl) in VSMCs at passage 3 resulted in a reduction in Aoc3 mRNA (<sup>####</sup> <i>p</i> < 0.0001 for Si6 vs. Sictrl and <sup>###</sup> <i>p</i> < 0.001 for Si8 vs. Sictrl) and VAP-1 protein (<sup>#</sup> <i>p</i> < 0.05 for Si8 vs. Sictrl). These novel findings demonstrate a passage dependent decrease in LOX activity and increase in SSAO activity in rat aortic VSMCs and show an association between both enzymes in early passage rat aortic VSMCs, where LOX was identified as a regulator of SSAO activity, protein, and mRNA expression.
first_indexed 2024-03-09T19:14:33Z
format Article
id doaj.art-c862ab248cf44c07b9808abe8d60a3fc
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-09T19:14:33Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-c862ab248cf44c07b9808abe8d60a3fc2023-11-24T03:52:41ZengMDPI AGBiomolecules2218-273X2022-10-011211156310.3390/biom12111563Semicarbazide-Sensitive Amine Oxidase (SSAO) and Lysyl Oxidase (LOX) Association in Rat Aortic Vascular Smooth Muscle CellsVesna Manasieva0Shori Thakur1Lisa A. Lione2Jessal Patel3Anwar Baydoun4John Skamarauskas5Imperial Biomedical Research Centre, Hammersmith Hospital, Department of Metabolism, Digestion and Reproduction, School of Medicine, Imperial College, London W12 0NN, UKCentre for Health Services and Clinical Research, Basic and Clinical Science Unit, Department of Clinical, Pharmaceutical and Biological Science, School of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9AB, UKCentre for Health Services and Clinical Research, Basic and Clinical Science Unit, Department of Clinical, Pharmaceutical and Biological Science, School of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9AB, UKCentre for Health Services and Clinical Research, Basic and Clinical Science Unit, Department of Clinical, Pharmaceutical and Biological Science, School of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9AB, UKLeicester Institute of Pharmaceutical Innovation for Integrated Care (LIPIIC), Health and Life Sciences, De Montfort University, The Gateway, Leicester LE1 9BH, UKCentre for Health Services and Clinical Research, Basic and Clinical Science Unit, Department of Clinical, Pharmaceutical and Biological Science, School of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9AB, UKVascular smooth muscle cells (VSMCs) are the main stromal cells in the medial layer of the vascular wall. These cells produce the extracellular matrix (ECM) and are involved in many pathological changes in the vascular wall. Semicarbazide-sensitive amine oxidase (SSAO) and lysyl oxidase (LOX) are vascular enzymes associated with the development of atherosclerosis. In the vascular smooth muscle cells, increased SSAO activity elevates reactive oxygen species (ROS) and induces VSMCs death; increased LOX induces chemotaxis through hydrogen peroxide dependent mechanisms; and decreased LOX contributes to endothelial dysfunction. This study investigates the relationship between SSAO and LOX in VSMCs by studying their activity, protein, and mRNA levels during VSMCs passaging and after silencing the LOX gene, while using their respective substrates and inhibitors. At the basal level, LOX activity decreased with passage and its protein expression was maintained between passages. βAPN abolished LOX activity (** <i>p</i> < 0.01 for 8 vs. 3 and * <i>p</i> < 0.05 for 5 vs. 8) and had no effect on LOX protein and mRNA levels. MDL72527 reduced LOX activity at passage 3 and 5 (<sup>##</sup> <i>p</i> < 0.01) and had no effect on LOX protein, and mRNA expression. At the basal level, SSAO activity also decreased with passage, and its protein expression was maintained between passages. MDL72527 abolished SSAO activity (**** <i>p</i> < 0.0001 for 8 vs. 3 and * <i>p</i> < 0.05 for 5 vs. 8), VAP-1 expression at passage 5 (** <i>p</i> < 0.01) and 8 (**** <i>p</i> < 0.0001), and Aoc3 mRNA levels at passage 8 (* <i>p</i> < 0.05). βAPN inhibited SSAO activity (**** <i>p</i> < 0.0001 for 5 vs. 3 and 8 vs. 3 and * <i>p</i> < 0.05 for 5 vs. 8), VAP-1 expression at passage 3 (* <i>p</i> < 0.05), and Aoc3 mRNA levels at passage 3 (* <i>p</i> < 0.05). Knockdown of the LOX gene (**** <i>p</i> < 0.0001 for Si6 vs. Sictrl and *** <i>p</i> < 0.001 for Si8 vs. Sictrl) and LOX protein (** <i>p</i> < 0.01 for Si6 and Si8 vs. Sictrl) in VSMCs at passage 3 resulted in a reduction in Aoc3 mRNA (<sup>####</sup> <i>p</i> < 0.0001 for Si6 vs. Sictrl and <sup>###</sup> <i>p</i> < 0.001 for Si8 vs. Sictrl) and VAP-1 protein (<sup>#</sup> <i>p</i> < 0.05 for Si8 vs. Sictrl). These novel findings demonstrate a passage dependent decrease in LOX activity and increase in SSAO activity in rat aortic VSMCs and show an association between both enzymes in early passage rat aortic VSMCs, where LOX was identified as a regulator of SSAO activity, protein, and mRNA expression.https://www.mdpi.com/2218-273X/12/11/1563semicarbazide sensitive amine oxidase (SSAO)lysyl oxidase (LOX)copper amine oxidasesvascular smooth muscle cellsMDL72527βAPN
spellingShingle Vesna Manasieva
Shori Thakur
Lisa A. Lione
Jessal Patel
Anwar Baydoun
John Skamarauskas
Semicarbazide-Sensitive Amine Oxidase (SSAO) and Lysyl Oxidase (LOX) Association in Rat Aortic Vascular Smooth Muscle Cells
Biomolecules
semicarbazide sensitive amine oxidase (SSAO)
lysyl oxidase (LOX)
copper amine oxidases
vascular smooth muscle cells
MDL72527
βAPN
title Semicarbazide-Sensitive Amine Oxidase (SSAO) and Lysyl Oxidase (LOX) Association in Rat Aortic Vascular Smooth Muscle Cells
title_full Semicarbazide-Sensitive Amine Oxidase (SSAO) and Lysyl Oxidase (LOX) Association in Rat Aortic Vascular Smooth Muscle Cells
title_fullStr Semicarbazide-Sensitive Amine Oxidase (SSAO) and Lysyl Oxidase (LOX) Association in Rat Aortic Vascular Smooth Muscle Cells
title_full_unstemmed Semicarbazide-Sensitive Amine Oxidase (SSAO) and Lysyl Oxidase (LOX) Association in Rat Aortic Vascular Smooth Muscle Cells
title_short Semicarbazide-Sensitive Amine Oxidase (SSAO) and Lysyl Oxidase (LOX) Association in Rat Aortic Vascular Smooth Muscle Cells
title_sort semicarbazide sensitive amine oxidase ssao and lysyl oxidase lox association in rat aortic vascular smooth muscle cells
topic semicarbazide sensitive amine oxidase (SSAO)
lysyl oxidase (LOX)
copper amine oxidases
vascular smooth muscle cells
MDL72527
βAPN
url https://www.mdpi.com/2218-273X/12/11/1563
work_keys_str_mv AT vesnamanasieva semicarbazidesensitiveamineoxidasessaoandlysyloxidaseloxassociationinrataorticvascularsmoothmusclecells
AT shorithakur semicarbazidesensitiveamineoxidasessaoandlysyloxidaseloxassociationinrataorticvascularsmoothmusclecells
AT lisaalione semicarbazidesensitiveamineoxidasessaoandlysyloxidaseloxassociationinrataorticvascularsmoothmusclecells
AT jessalpatel semicarbazidesensitiveamineoxidasessaoandlysyloxidaseloxassociationinrataorticvascularsmoothmusclecells
AT anwarbaydoun semicarbazidesensitiveamineoxidasessaoandlysyloxidaseloxassociationinrataorticvascularsmoothmusclecells
AT johnskamarauskas semicarbazidesensitiveamineoxidasessaoandlysyloxidaseloxassociationinrataorticvascularsmoothmusclecells